8月4日周一盘中，Twist Bioscience Corp（TWST）股价大幅下跌10.72%，引发市场广泛关注。这家合成生物学公司的股价暴跌与其刚刚发布的2025财年第三季度财务业绩密切相关。
Twist Bioscience是一家专注于合成DNA和基因组学研究的生物技术公司。在周一早间交易开始前，公司公布了其最新季度财报。虽然具体财务数据尚未完全披露，但市场反应表明，公司的业绩可能远低于分析师预期。此前，分析师平均预计公司每股亏损为0.53美元。
投资者对这份财报反应强烈，导致股价在盘中大幅下挫。这一走势表明，Twist Bioscience的财务状况可能比预期更为糟糕，引发了市场对公司未来发展前景的担忧。在生物科技行业竞争日益激烈的背景下，Twist Bioscience面临的挑战可能比预期更为严峻。投资者现在将密切关注公司管理层在随后的财报电话会议上的解释和未来战略规划。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.